Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2619 (LINC02619)
- Target
- LINC02619
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2619 (LINC02619) is a human gene that encodes a long non-coding RNA belonging to the intergenic subset of lncRNAs, characterized by transcription from regions outside protein-coding genes, typically longer than 200 nucleotides[1][3][7]. LINC02619 has no known protein-coding function. Like other lincRNAs, its putative biological functions may include regulation of chromatin states, influence on gene expression through enhancer-like activity, and scaffolding or modulation of protein complexes[1]. LINC02619 is annotated and catalogued in genomic resources but has not been functionally characterized or implicated in specific disease processes. It is not considered a conventional druggable target or biomarker.
- Other names
- LINC02619Long intergenic non-protein coding RNA 2619
02
Mechanism of action
Not applicable; no drugs or clinical agents known to target LINC02619.
03
Biological functions
Chromatin remodelingRegulation of genome architectureRNA stabilizationGene expression regulation, including enhancer-associated activityPotential scaffolding and modulation of protein complexes
04
Disease associations
No specific disease roles or biomarkers are known for LINC02619.Most lincRNAs, including this family, are increasingly implicated in various cancers, developmental disorders, and other gene regulation-associated diseases.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2619 (LINC02619).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2619 (LINC02619).